Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristel Kemper

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Oncotarget|February 12, 2011
Molecular identification and targeting of colorectal cancer stem cellsKristel Kemper, Catarina Grandela, Jan Paul Medema
Pigment Cell & Melanoma Research|March 22, 2016
MITF: More Interesting Traits, Folks!Kristel Kemper, Oscar Krijgsman, Daniel S Peeper
Plos One|September 3, 2010
Mouse tissues express multiple splice variants of prominin-1Kristel Kemper, Marc J P M Tol, Jan Paul Medema
Apoptosis : an International Journal on Programmed Cell Death|January 7, 2012
Targeting colorectal cancer stem cells with inducible caspase-9Kristel Kemper, Hans Rodermond, Selçuk Colak, et al.
Cancer Research|October 17, 2014
Phenotype switching: tumor cell plasticity as a resistance mechanism and target for therapyKristel Kemper, Pauline L de Goeje, Daniel S Peeper, et al.
Frontiers in Oncology|February 25, 2025
Improving CD3 bispecific antibody therapy in solid tumors using combination strategiesKaty Lloyd, Jim Middelburg, Vitalijs Ovcinnikovs, et al.
Cancers|January 20, 2021
Overcoming Challenges for CD3-Bispecific Antibody Therapy in Solid TumorsJim Middelburg, Kristel Kemper, Patrick Engelberts, et al.
Stem Cells (Dayton, Ohio)|September 13, 2012
Monoclonal antibodies against Lgr5 identify human colorectal cancer stem cellsKristel Kemper, Pramudita R Prasetyanti, Wim De Lau, et al.
Cancer Research|February 19, 2008
Cyclooxygenase-2 inhibition inhibits c-Met kinase activity and Wnt activity in colon cancerJurriaan B Tuynman, Louis Vermeulen, Elles M Boon, et al.
Journal for Immunotherapy of Cancer|January 12, 2025
Cancer vaccines compensate for the insufficient induction of protective tumor-specific immunity of CD3 bispecific antibody therapyJim Middelburg, Gaby Schaap, Marjolein Sluijter, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Oncotarget|February 12, 2011
Molecular identification and targeting of colorectal cancer stem cellsKristel Kemper, Catarina Grandela, Jan Paul Medema
Pigment Cell & Melanoma Research|March 22, 2016
MITF: More Interesting Traits, Folks!Kristel Kemper, Oscar Krijgsman, Daniel S Peeper
Plos One|September 3, 2010
Mouse tissues express multiple splice variants of prominin-1Kristel Kemper, Marc J P M Tol, Jan Paul Medema
Apoptosis : an International Journal on Programmed Cell Death|January 7, 2012
Targeting colorectal cancer stem cells with inducible caspase-9Kristel Kemper, Hans Rodermond, Selçuk Colak, et al.
Cancer Research|October 17, 2014
Phenotype switching: tumor cell plasticity as a resistance mechanism and target for therapyKristel Kemper, Pauline L de Goeje, Daniel S Peeper, et al.
Frontiers in Oncology|February 25, 2025
Improving CD3 bispecific antibody therapy in solid tumors using combination strategiesKaty Lloyd, Jim Middelburg, Vitalijs Ovcinnikovs, et al.
Cancers|January 20, 2021
Overcoming Challenges for CD3-Bispecific Antibody Therapy in Solid TumorsJim Middelburg, Kristel Kemper, Patrick Engelberts, et al.
Stem Cells (Dayton, Ohio)|September 13, 2012
Monoclonal antibodies against Lgr5 identify human colorectal cancer stem cellsKristel Kemper, Pramudita R Prasetyanti, Wim De Lau, et al.
Cancer Research|February 19, 2008
Cyclooxygenase-2 inhibition inhibits c-Met kinase activity and Wnt activity in colon cancerJurriaan B Tuynman, Louis Vermeulen, Elles M Boon, et al.
Journal for Immunotherapy of Cancer|January 12, 2025
Cancer vaccines compensate for the insufficient induction of protective tumor-specific immunity of CD3 bispecific antibody therapyJim Middelburg, Gaby Schaap, Marjolein Sluijter, et al.
Pageof 4